COVID-19 diagnosis on the basis of nanobiosensors’ prompt interactivity: A holistic review

• Published in: Pathology, research and practice research and practice, 2024-10, Vol.262, p.155565, Article 155565
• Main Authors: Mohammadi, Mohammad, Asvar, Zahra, Solhjoo, Seyyed Pooria, Sarikhanikhorrami, Mohammad, Abadi, Hassan Ghader, Ghazizadeh, Shirin, Mahmoodi, Hassan, Habibolah, Niloofar Karbalaee, Moradi, Omar, Kesharwani, Prashant, Amani, Ali Mohammad, Sahebkar, Amirhossein
• Format: Article
• Language: English
• Subjects: Biosensing Techniques - methods; Biosensor; COVID-19; COVID-19 - diagnosis; COVID-19 Testing - methods; Detection; Humans; Nanomaterials; Nanotechnology; SARS-CoV-2
• ISSN: 0344-0338; 1618-0631; 1618-0631
• DOI: 10.1016/j.prp.2024.155565

The fast spread and severe consequences of novel coronavirus disease 2019 (COVID-19) have once again underscored the critical necessity of early detection of viral infections. Several serology-based techniques, including as point-of-care assays and high-throughput enzyme immunoassays that support the diagnosis of COVID-19 are utilized in the detection and identification of coronaviruses. A rapid, precise, simple, affordable, and adaptable diagnostic tool is required for controlling COVID-19 as well as for outbreak management, since the calculation and monitoring of viral loads are crucial for predicting the infection stage and recovery time. Nowadays, the most popular method for diagnosing COVID-19 is reverse transcription polymerase chain reaction (RT-PCR) testing, and chest computed tomography (CT) scans are also used to determine the disease's phases. This is all because of the fact that RT-PCR method caries with itself a number of downsides comprising of being immovable, expensive, and laborious. RT-PCR has not well proven to be capable of detection on the very early infection stages. Nanomaterial-based diagnostics, together with traditional clinical procedures, have a lot of promise against COVID-19. It is worthy of attention that nanotechnology has the mainstay capacity for purposes of developing even more modern stratagems fighting COVID-19 by means of focusing on state-of-the-art diagnostics. What we have centered on in this review, is bringing out even more efficient detection techniques whereby nanobiosensors are employed so that we might obstruct any further development and spreading of SARS-CoV-2.